Imunon’s CEO discusses how FDA allowing the Bayesian method impacts innovation in the clinical trial space.
Stacy Musone
Advertisement
Articles by Stacy Musone
Members of PacBio and iHope discuss collaboration and the global state of genomic testing.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Lessons Learned in the Current Biotech Funding Environment
2
The Long Wait for Rare Disease Treatment Approval: Q&A with Dr. Patricia E. Greenstein
3
Regeneron Agrees to Lower Drug Costs for U.S. Patients and Provide Otarmeni for Free
4
FDA Issues CRL to AbbVie for TrenibotulinumtoxinE’s Biologics License Application
5